DI MAURO, GABRIELLA
 Distribuzione geografica
Continente #
EU - Europa 2.222
AS - Asia 942
NA - Nord America 832
SA - Sud America 170
AF - Africa 18
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.186
Nazione #
RU - Federazione Russa 1.535
US - Stati Uniti d'America 816
SG - Singapore 296
IT - Italia 289
VN - Vietnam 183
CN - Cina 182
IE - Irlanda 174
BR - Brasile 138
HK - Hong Kong 130
GB - Regno Unito 58
DE - Germania 55
KR - Corea 40
IN - India 34
JP - Giappone 25
FR - Francia 20
AR - Argentina 16
FI - Finlandia 15
NL - Olanda 13
UA - Ucraina 12
GR - Grecia 11
BD - Bangladesh 9
ID - Indonesia 9
AT - Austria 8
MX - Messico 8
IQ - Iraq 7
ZA - Sudafrica 7
EC - Ecuador 6
ES - Italia 6
PL - Polonia 6
SA - Arabia Saudita 5
BE - Belgio 4
IR - Iran 4
TR - Turchia 4
CA - Canada 3
CL - Cile 3
CZ - Repubblica Ceca 3
KH - Cambogia 3
RS - Serbia 3
VE - Venezuela 3
BG - Bulgaria 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
KE - Kenya 2
LT - Lituania 2
MA - Marocco 2
PH - Filippine 2
PK - Pakistan 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AQ - Antartide 1
BH - Bahrain 1
CH - Svizzera 1
CO - Colombia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
SE - Svezia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 4.186
Città #
Moscow 549
San Jose 178
Dublin 173
Singapore 151
Hong Kong 129
Santa Clara 112
Dong Ket 56
Ashburn 55
Naples 52
Chandler 49
Ho Chi Minh City 48
Seoul 40
Hanoi 32
Beijing 31
Jacksonville 31
Hefei 29
Aversa 27
Bremen 23
Ann Arbor 22
Princeton 21
Roxbury 21
Los Angeles 18
Bengaluru 16
Rome 16
Lodi 14
New York 14
São Paulo 14
Caserta 12
Cambridge 11
Haiphong 10
Medford 10
Munich 10
Da Nang 9
Dallas 9
The Dalles 9
Helsinki 8
Woodbridge 8
Chennai 7
Memphis 7
Salerno 7
London 6
Orem 6
Cagliari 5
Jakarta 5
Manchester 5
Milan 5
Wilmington 5
Amsterdam 4
Brussels 4
Curitiba 4
Dearborn 4
Ercolano 4
Falkenstein 4
Guangzhou 4
Hanover 4
Mexico City 4
Palermo 4
Wroclaw 4
Atlanta 3
Baghdad 3
Buffalo 3
Caivano 3
Council Bluffs 3
Des Moines 3
Frankfurt am Main 3
Hillsboro 3
Johannesburg 3
Lamezia Terme 3
Lappeenranta 3
Mezzano 3
Montpellier 3
Monza 3
Mountain View 3
Nanjing 3
Newark 3
Nuremberg 3
Phnom Penh 3
Phủ Lý 3
Pomigliano d'Arco 3
Quito 3
St Petersburg 3
Turin 3
Vadodara 3
Vienna 3
Afragola 2
Ardea 2
Arezzo 2
Asunción 2
Auburn Hills 2
Boardman 2
Boydton 2
Brasília 2
Breda 2
Brookline 2
Buenos Aires 2
Cairo 2
Campinas 2
Cape Town 2
Cariacica 2
Caxias do Sul 2
Totale 2.229
Nome #
Adverse drug reactions and gender differences: What changes in drug safety? 227
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 181
Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment 180
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 179
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 176
Current and future therapeutic perspective in chronic heart failure 157
Preliminary results of the FASM study, an on-going italian active pharmacovigilance project 154
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study 152
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events 145
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 144
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 137
Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System 136
Recommendations on Complementary Feeding as a Tool for Prevention of Non-Communicable Diseases (NCDs)—Paper Co-Drafted by the SIPPS, FIMP, SIDOHaD, and SINUPE Joint Working Group 133
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 128
The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis 127
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 123
Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System 122
Inter-society consensus for the use of inhaled corticosteroids in infants, children and adolescents with airway diseases 121
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS) 118
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis 117
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 111
Correction: Inter-society consensus for the use of inhaled corticosteroids in infants, children and adolescents with airway diseases 109
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 108
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 106
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 106
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 105
Treatment of acute pharyngitis in children: an Italian intersociety consensus (SIPPS-SIP-SITIP-FIMP-SIAIP-SIMRI-FIMMG) 104
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 103
The European clinical trials regulation (No 536/2014): changes and challenges 96
Terapie CAR-T e tumori secondari a cellule T: analisi delle segnalazioni di sospette reazioni avverse dalla banca dati di farmacovigilanza FAERS 95
Immune checkpoint inhibitors and metabolic events: results from a European safety analysis. 88
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. 82
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment 78
Totale 4.248
Categoria #
all - tutte 13.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.828


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 0 0 0 0 0 0 58
2021/2022132 1 7 0 0 32 5 4 4 16 7 8 48
2022/2023340 43 20 8 15 40 19 10 5 157 3 11 9
2023/2024174 12 5 7 10 38 12 8 14 12 13 17 26
2024/2025576 0 15 9 16 75 75 87 63 96 53 40 47
2025/20262.775 107 126 129 132 248 1.401 150 193 88 89 58 54
Totale 4.248